Transforming Practice and Policy Through Science: A Joint Conference on Child, Youth and Emerging Adult Mental Health

Transforming Practice and Policy Through Science: A Joint Conference on Child, Youth and Emerging Adult Mental Health

By Centre for Addiction and Mental Health

Date and time

Thursday, November 17, 2016 · 8am - 4:30pm EST

Location

CAMH - Queen Street Site

100 Stokes Street, Bell Gateway Building Sandi & Jim Treliving Gymnasium Toronto, ON M6J 1H4 Canada

Description

Join Us

Leading experts will share the latest in child and youth mental health and their vision of what the future holds.

Agenda

8:00 AM

Breakfast and Registration

9:00 AM

Welcome, CEO & donor remarks

Remarks by Dr. Catherine Zahn, Hon. Margaret McCain, Dr. Peter Szatmari, Dr. Aristotle Voineskos

9:45 AM

Dr. Ian Goodyer

The treatment of depressed adolescents: new findings and ways forward

10:30 AM

Morning break

10:45 AM

Dr. Kathryn Bennett

Practice guidelines and excellence in child and youth mental health care

11:30 AM

Dr. Kathleen Merikangas

Dissecting mood disorders in children and youth leading to better outcomes

12:15 PM

Lunch

1:15 PM

Dr. Jean Addington

Youth at risk of serious mental illness: what do we know and how can we help?

2:00 PM

Dr. Joanna Henderson

Increasing the clinical relevance of research: two examples from the Ontario context

2:45 PM

Afternoon break

3:00 PM

Panel discussion

Looking ahead: the next five years

3:30 PM

Closing remarks

3:45 PM

Departures


Keynote Speakers

Dr. Ian Goodyer
Professor of Child and Adolescent Psychiatry
Department of Psychiatry, Developmental Psychiatry Section
University of Cambridge

Dr. Ian Goodyer is a Child and Adolescent Psychiatrist based at Cambridge University pursuing research into the connections between human development and psychopathology. His studies are centred on adolescents in the community as well as current patients. His research program uses experimental and neuroimaging approaches embedded in longitudinal designs to measure the effects of genes and the social environment, on cognition and brain structures. They use these methods in epidemiological cohort studies of adolescent development and randomized controlled trials of treatment for depression and conduct disorders.

Dr. Kathleen R. Merikangas
Chief, Genetic Epidemiology Research Branch (GEB-SDGE)
National Institute of Mental Health

Dr. Kathleen Ries Merikangas is the Senior Investigator and Chief of the Genetic Epidemiology Research Branch in the Intramural Research Program at the National Institute of Mental Health (NIMH). Dr. Merikangas received a bachelor's degree summa cum laude in experimental psychology and music from the University of Notre Dame. She received clinical training through an NIAAA-sponsored master's program and internship at the Western Psychiatric Institute and Clinic at the University of Pittsburgh School of Medicine, where she continued to conduct clinical research on the Affective Disorders Clinical Research Unit while she pursued a Ph.D. in chronic disease epidemiology at the University of Pittsburgh School of Public Health. Through a Career Development Award from the NIMH, she completed postdoctoral training in population genetics/genetic epidemiology at the Yale University School of Medicine, where she joined the faculty and ultimately became a Professor of Epidemiology and Public Health, Psychiatry and Psychology and the Director of the Genetic Epidemiology Research Unit in the Department of Epidemiology and Public Health.

Dr. Jean Addington
Professor of Psychiatry
University of Calgary

Jean Addington, Ph.D., is a Professor of Psychiatry at the University of Calgary in Alberta, Canada. She is an Alberta Innovates Health Solutions Health Scientist and holds the Novartis Chair for Schizophrenia Research. Her research interests are in early detection and intervention in psychosis. She played a major role in setting up the Early Psychosis Program in Calgary and continued with this work at the University of Toronto and CAMH, where from 2002 – 2008, she was responsible for developing research on the prodromal phase of schizophrenia. Currently, her major research focus is on the examination of predictors of conversion to psychosis and the development of psychosocial interventions for those at clinical high risk of psychosis. She is one of the principal investigators in the North American Prodrome Longitudinal Study (NAPLS), and leads an NIMH funded RCT of Cognitive Behavioral Social Skills Training for clinical high risk. She recently received funding from Brain Canada to examine predictors of serious mental illness in youth at risk. She is currently Vice-President North America of the International Early Psychosis Association.

Who Should Attend

Service providers, policy-makers, youth partners, family partners, researchers and administrators interested in child, youth and emerging adult mental health.

Brought to you by the Centres of Innovation in the Child, Youth and Emerging Adult Program at the Centre for Addiction and Mental Health (CAMH):

- The Cundill Centre for Child and Youth Depression
- The Margaret and Wallace McCain Centre for Child Youth and Family Mental Health
- The Slaight Family Centre for Youth in Transition

Other Details

- Light breakfast and lunch included

Please register by Tuesday, November 8, 2016

Organized by

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in the area of addiction and mental health. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental health and addiction issues. 
Sales Ended